More Cogstate Ltd news
Cogstate LtdASX: CGS

Cogstate announces European approval for Cognigram

Jun 4, 2018 at 11:26 PM EDT · Issued by Cogstate Ltd

Filed with ASX · Jun 4, 2018 at 11:26 PM EDT

On 6ix: 6ix.com/news/cogstate-announces-european-approval-for-cognigram

Watch Cogstate's latest call↗Cogstate (ASX:CGS) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cogstate (ASX:CGS) Q4 2026 Earnings Call↗

Cogstate Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cogstate Ltd on 6ix

Story so far

  • Cogstate cleared by FDA to start marketing Cognigram in U.S.Jul 27, 2017
  • CogState launches Cognigram test in CanadaMar 30, 2016
  • Merck releases new data on effectiveness of CognigramMar 30, 2016

Earlier from Cogstate

  • Business Update & Appendix 4CApr 12, 2018
  • Cogstate Establishes Rare Disease and Pediatric ExpertiseApr 5, 2018
  • S&P DJ Indices Announces March Quarterly RebalanceMar 8, 2018
  • Appendix 4D & Half Year Financial ReportFeb 20, 2018
  • Global Alzheimer Platform Foundation Selects CogstateJan 24, 2018

Later from Cogstate

  • AD trial discontinued - limited CGS impactJun 12, 2018
  • Full Year Financial Results SummaryAug 12, 2018
  • AGM PresentationOct 23, 2018
  • Change of Director’s Interest NoticeOct 29, 2018
  • FY19 Half Year Results and Earnings GuidanceFeb 26, 2019
All Cogstate news releases↗

Follow Cogstate into a list and get an email when it puts out news.

Follow Cogstate
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer